APA (7th ed.) Citation

Sumbul, H. E., Isik, B., Mustan, A. G., Alisan, I., Erhan, C., Koca, F. I., . . . Koc, M. (2026). Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study. Journal of Clinical Medicine, 15(11), 4105. https://doi.org/10.3390/jcm15114105

Chicago Style (17th ed.) Citation

Sumbul, Hilmi Erdem, et al. "Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study." Journal of Clinical Medicine 15, no. 11 (2026): 4105. https://doi.org/10.3390/jcm15114105.

MLA (9th ed.) Citation

Sumbul, Hilmi Erdem, et al. "Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study." Journal of Clinical Medicine, vol. 15, no. 11, 2026, p. 4105, https://doi.org/10.3390/jcm15114105.